Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NEURODEGENERATIVE DISEASES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
NEURODEGENERATIVE DISEASES is a concept in neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with ALS, Aging, Als. Connected to 2536 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | NEURODEGENERATIVE DISEASES |
| Key Genes/Proteins | 6-OHDA, AADC, ABCA1, ABCA7, ABCD3, ABCG2 |
| Related Diseases | Aging |
| Related Pathways | Adaptive Immunity |
graph TD
subgraph Signaling["Signaling"]
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| NEURODEGENERATIVE_DISORDERS["NEURODEGENERATIVE DISORDERS"]
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| AUTOPHAGY["AUTOPHAGY"]
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| Neurodegeneration["Neurodegeneration"]
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| Autophagy["Autophagy"]
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| Apoptosis["Apoptosis"]
APOPTOSIS["APOPTOSIS"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
PARKINSON_S_DISEASE_2["PARKINSON'S DISEASE"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
end
subgraph Therapeutic["Therapeutic"]
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"therapeutic target"| ALS["ALS"]
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"therapeutic target"| Als["Als"]
PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"therapeutic target"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
TAU["TAU"] -->|"therapeutic target"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
end
subgraph Pathology["Pathology"]
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"contributes to"| Alzheimer["Alzheimer"]
NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"associated with"| AMYOTROPHIC_LATERAL_SCLEROSIS["AMYOTROPHIC LATERAL SCLEROSIS"]
PARKINSON_S_DISEASE_1["PARKINSON'S DISEASE"] -->|"associated with"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
end
style NEURODEGENERATIVE_DISEASES fill:#90a4ae,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style NEURODEGENERATIVE_DISORDERS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Apoptosis fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AMYOTROPHIC_LATERAL_SCLEROSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style PARKINSON_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style PARKINSON_S_DISEASE_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style PARKINSON_S_DISEASE_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style OXIDATIVE_STRESS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Oxidative Stress | activates | pathway | 1.00 |
| Inflammation | activates | disease | 1.00 |
| INFLAMMATION | regulates | gene | 1.00 |
| Stroke | therapeutic_target | disease | 1.00 |
| Parkinson | activates | disease | 1.00 |
| NEUROINFLAMMATION | activates | gene | 1.00 |
| Oxidative Stress | therapeutic_target | pathway | 1.00 |
| Neuroinflammation | therapeutic_target | disease | 1.00 |
| MITOCHONDRIAL DYSFUNCTION | therapeutic_target | gene | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| NEUROINFLAMMATION | associated_with | gene | 1.00 |
| Multiple Sclerosis | therapeutic_target | disease | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Apoptosis | therapeutic_target | pathway | 1.00 |
| Immune Response | therapeutic_target | pathway | 1.00 |
| Als | activates | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| NEUROINFLAMMATION | regulates | gene | 1.00 |
| NEURODEGENERATIVE DISORDERS | regulates | gene | 1.00 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 1.00 |
| Als | expressed_in | disease | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Alzheimer | regulates | disease | 1.00 |
| Neurodegeneration | regulates | disease | 1.00 |
| AMYOTROPHIC LATERAL SCLEROSIS | therapeutic_target | gene | 1.00 |
| NEURODEGENERATIVE DISORDERS | therapeutic_target | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| Neurodegeneration | therapeutic_target | disease | 1.00 |
| Huntington | therapeutic_target | disease | 1.00 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 1.00 |
| Parkinson | therapeutic_target | disease | 1.00 |
| ALS | therapeutic_target | gene | 1.00 |
| Aging | activates | disease | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| Tumor | activates | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| NEURODEGENERATIVE DISORDERS | activates | gene | 1.00 |
| AUTOPHAGY | therapeutic_target | gene | 1.00 |
| Huntington | activates | disease | 1.00 |
| Tauopathy | activates | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Mtor | activates | pathway | 1.00 |
| ALZHEIMER'S DISEASE | regulates | gene | 1.00 |
| Autophagy | therapeutic_target | pathway | 1.00 |
| Neuroinflammation | regulates | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PARKINSON'S DISEASE | regulates | gene | 1.00 |
| HUNTINGTON | associated_with | gene | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| CANCER | associated_with | gene | 1.00 |
| APOPTOSIS | therapeutic_target | gene | 1.00 |
| PARKINSON | associated_with | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| NEURODEGENERATION | causes | gene | 1.00 |
| NF-ΚB | activates | gene | 1.00 |
| OXIDATIVE STRESS | associated_with | gene | 1.00 |
| HUNTINGTON | activates | gene | 1.00 |
| ALZHEIMER | treats | gene | 1.00 |
| NEURODEGENERATION | regulates | gene | 1.00 |
| OXIDATIVE STRESS | regulates | gene | 1.00 |
| HUNTINGTON | targets | gene | 1.00 |
| AMPK | activates | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| ALZHEIMER | causes | gene | 1.00 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 1.00 |
| ALZHEIMER | expressed_in | gene | 1.00 |
| PARKINSON | activates | gene | 1.00 |
| ALZHEIMER | regulates | gene | 1.00 |
| ALZHEIMER | therapeutic_target | gene | 1.00 |
| NEUROTOXICITY | activates | gene | 1.00 |
| PARKINSON | therapeutic_target | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| NEURODEGENERATION | targets | gene | 1.00 |
| APOPTOSIS | regulates | gene | 1.00 |
| PARKINSON | causes | gene | 1.00 |
| TAU | therapeutic_target | gene | 1.00 |
| PARKINSON'S DISEASE | causes | gene | 1.00 |
| OXIDATIVE STRESS | therapeutic_target | gene | 1.00 |
| PARKINSON | regulates | gene | 1.00 |
| PARKINSON'S DISEASE | activates | gene | 1.00 |
| NEURODEGENERATION | treats | gene | 1.00 |
| PARKINSON'S DISEASE | associated_with | gene | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| TNF | activates | gene | 1.00 |
| TAU | associated_with | gene | 1.00 |
| ROS | activates | gene | 1.00 |
| NEURODEGENERATION | biomarker_for | gene | 1.00 |
| TAU | activates | gene | 1.00 |
| SIRT1 | activates | gene | 1.00 |
| NEUROTOXICITY | therapeutic_target | gene | 1.00 |
| ALZHEIMER | inhibits | gene | 1.00 |
| BDNF | activates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| microglial priming across neurodegenerative diseases should | 0.577 | neurodegeneration | Microglial Priming as Upstream Causal No |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-27 | 7 hypotheses Top: 0.710
neurodegeneration | 2026-04-07 | 5 hypotheses Top: 0.718
neurodegeneration | 2026-04-01 | 0 hypotheses
neurodegeneration | 2026-04-01 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.77 · 2026-04-28
closed · Rounds: 4 · Score: 0.65 · 2026-04-21
closed · Rounds: 5 · Score: 0.95 · 2026-04-01
closed · Rounds: 4 · Score: 0.95 · 2026-04-01
Hypotheses and analyses mentioning NEURODEGENERATIVE DISEASES in their description or question text
No additional research found